Endogenous / BiologyEndogenousHuman-supportedUpdated 2026-04-24

Peptide reference file

Adrenomedullin

Trending #42 in Endogenous2.1k searches/moProven

Adrenomedullin is an endogenous vasoactive peptide involved in cardiovascular, renal, and inflammatory signaling.

Current readout: human-supported evidence, endogenous status, endogenous approval state, human evidence appears in the current trail, registered trials are linked, and 3 linked sources in the seed trail.

PubChem CID 56841671 | 4293 PubMed results | 34 trial records | 0 DailyMed labels | 0 Drugs@FDA applications

Adrenomedullin is mostly discussed because it belongs in the index because peptide biology extends deep into vascular and critical-care physiology.

The public claim is straightforward: It belongs in the index because peptide biology extends deep into vascular and critical-care physiology. Useful physiology reference entry with substantial biological support.

In plain language, adrenomedullin is an endogenous vasoactive peptide involved in cardiovascular, renal, and inflammatory signaling.

Human-supportedEndogenous
Vasoactive peptideFluid balanceCardiovascular signaling

Aliases: ADM peptide

SpecimenAdrenomedullin specimen
CCCCCHHHHHHHNOS
Formula
C264H406N80O77S3
Mass
6029
Evidence
Human-supported
Elements
5

Most commonly discussed in relation to Vasoactive peptide, Fluid balance, Cardiovascular signaling.

What Adrenomedullin is

Adrenomedullin is an endogenous vasoactive peptide involved in cardiovascular, renal, and inflammatory signaling.

Adrenomedullin is grouped under Endogenous / Biology on PeptideFactCheck because it belongs in the index because peptide biology extends deep into vascular and critical-care physiology.

The useful starting point is to separate the molecule itself from the internet story around it. It belongs in the index because peptide biology extends deep into vascular and critical-care physiology.

Why people keep looking it up

It belongs in the index because peptide biology extends deep into vascular and critical-care physiology.

Adrenomedullin is an endogenous vasoactive peptide involved in cardiovascular, renal, and inflammatory signaling.

Adrenomedullin tends to stay in the conversation because it touches a familiar public theme: vasoactive peptide, fluid balance, and cardiovascular signaling. That makes it easy for the claim to travel faster than the evidence.

What the evidence can support right now

Useful physiology reference entry with substantial biological support.

Human physiology is established, though this is mainly a biology-reference entry.

Mechanistic support across vascular and inflammatory biology is strong.

Why this page carries the current tier: Useful physiology reference entry with substantial biological support.

The current seed trail for Adrenomedullin is pulling from 2 databases sources and 1 literature source.

Safety, limits, and regulatory context

Broad physiological peptides are easy to misunderstand when stripped out of context.

Adrenomedullin is tracked here as endogenous biology.

Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for Adrenomedullin. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.

Molecular and identifier data

The current PubChem match for Adrenomedullin is CID 56841671. That gives the page a source-backed chemistry record rather than a placeholder identifier block.

PubChem CID
56841671
Formula
C264H406N80O77S3
Molecular weight
6029
InChIKey
ULCUCJFASIJEOE-NPECTJMMSA-N

Matched synonyms include Human adrenomedullin, Adrenomedullin (human), Human adrenomedullin(1-52), Human adrenomedullin-(1-52)-NH2, RefChem:317311, 148498-78-6, Adrenomedullin, DA-70610.

Open PubChem record

Clinical trial snapshot

The current ClinicalTrials.gov intervention query for Adrenomedullin returns 34 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.

Literature snapshot

The current PubMed query for Adrenomedullin returns 4293 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.

Source trail

Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.

Safety noteThis content is educational only and does not replace medical advice. Peptide use may carry risks and should be discussed with a qualified medical professional.